Mutares’s €6.5 Billion Revenue Surge Overshadowed by Debt Covenant Breach

Mutares posts blockbuster 2025 revenue of €6.5B and net profit of €130.4M, yet stock languishes 22% lower due to a bond covenant breach, with a waiver expiring June 29.

Mutares has delivered a blockbuster set of 2025 numbers, with revenue leaping from €5.3 billion to €6.5 billion and the holding company’s net profit climbing to €130.4 million. Yet the stock continues to languish, trading at around €25.00 — roughly 22% below where it stood a year ago and 16% lower than its starting point for 2025. The disconnect between operational momentum and market sentiment stems from a single, stubborn issue: a covenant breach on two outstanding bonds.

Debt Waiver Bought Time Until Late June

The ratio of net debt to equity had breached the threshold agreed in the bond terms, triggered by a combination of valuation effects, fewer value-enhancing transactions in the final quarter of 2025, and a sharp rise in leasing liabilities. Mutares was forced to launch a formal waiver process for its Nordic Bonds 2023/27 and 2024/29, and creditors have agreed to temporarily forgo their right to call in the debt. That reprieve runs only until 29 June, giving management a tight window to restructure the balance sheet.

The board expects the key metric to return to compliance by the end of June 2026, supported by the already-signed acquisitions of Wärtsilä Gas Solutions and SABIC’s ETP business. In parallel, the company plans to reduce outstanding bond debt from €385 million to between €250 million and €300 million. A voluntary tender offer for bondholders is expected to launch around 8 May.

Adjusted EBITDA Still in the Red Despite Headline Gains

The headline EBITDA figure surged from €117 million to €675 million, boosted heavily by the full exit from Steyr Motors. But the adjusted EBITDA — the metric that strips out one-off effects and is more closely watched by analysts covering private-equity style holding companies — remained negative at minus €31.2 million. That marks an improvement from minus €85.4 million a year earlier, but it underscores that underlying portfolio profitability has not yet turned positive.

The aggressive expansion strategy is clearly visible in the numbers. Management closed 17 acquisitions in 2025, generating roughly €731 million in so-called bargain-purchase gains — nearly triple the prior year’s figure. Gains from corporate disposals added another €161 million. Around a tenth of the new acquisitions underperformed expectations, but the adjusted operating result still improved noticeably.

Dividend Proposal and Exit Pipeline

Shareholders are set to benefit from the recent cash inflows. The board will propose a dividend of €2.00 per share at the annual general meeting scheduled for 3 July. Management has framed this as a minimum payout, leaving the door open for an additional performance-linked dividend if further exits with material liquidity contributions are completed before the meeting.

Ten portfolio companies are already on the internal list for near-term disposal, and the board is targeting 2026 disposal proceeds well above €230 million. That exit pipeline is central to the holding company’s profit forecast for the current year, which calls for a net profit of between €165 million and €200 million. The broader group revenue target for 2026 sits between €7.9 billion and €9.1 billion, with a long-term ambition of at least 25% annual revenue growth through to 2030.

Portfolio Bright Spots and a New Segment

Among the portfolio highlights, fire-engine manufacturer Magirus posted a record order intake in the first quarter of 2026, with its order book now exceeding €800 million. The SABIC transaction is laying the groundwork for a new “Chemicals & Materials” segment, marking Mutares’s first foray into specialty chemicals and high-performance materials.

The company’s cash position for new deals has been bolstered by a recently completed capital raise, with proceeds earmarked primarily for the US market. Technically, however, the stock remains under pressure. The share price is trading well below its 50-day moving average of €28.46, and no quick buy signal is visible in the current volatile environment.

First-Quarter Report as a Litmus Test

The next major milestone comes on 12 May, when Mutares releases its first-quarter report for 2026. That update will show whether the covenant timeline is holding and whether the balance sheet restructuring is on track. For now, investors are weighing a company that is growing at breakneck speed against one that still has a structural debt issue to resolve before the end of June.